< Back to previous page

Patent

Functional cure of retroviral infection

The application relates to methods of curing retroviral infections, i.e. ensuring remission of retroviral infections, more particularly HIV infections, by administering a compound which is capable of binding to the LEDGF/p75 binding pocket of HIV-integrase and inhibiting LEDGF/p75-IN protein-protein interaction. The application further relates to the use of LEDGINs in retroviral gene therapy.
Patent Publication Number: EP3294277
Source: EPO
Year approval: 2021
Year publication: 2021
Status: Assigned
Technology domains: Pharmaceuticals
Validated for IOF-key: Yes